Ginkgo Bioworks Holdings DNA paid Forbes-Tate $80K for lobbying in Q1 2023 · Health Issues, Science and 2 more issues

Trade details

Type: Lobbying report
Amount: $80,000
Quarter: Q1 2023
Stock: Ginkgo Bioworks Holdings DNA
Client: Ginkgo Bioworks
Reported: 23/04/17

Up 0.0% from last quarter

What else happened in Ginkgo Bioworks Holdings around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Ginkgo Bioworks's other lobbying reports

Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 07/18
for Q2
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 07/10
for Q2
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 04/20
for Q1
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$60K
$60K
Reported 04/15
for Q1
Ginkgo Bioworks
LobbyingGinkgo Bioworks Holdings
Lobbying
Ginkgo Bioworks Holdings
DNA
$30K
$30K
Reported 01/20
for Q4 2025

Ginkgo Bioworks Holdings DNA paid Forbes-Tate $80K for lobbying in Q1 2023 · Health Issues, Science and 2 more issues | Whalegun